Henry Schein CEO talks antibiotics at World Economic Forum
Stanley Bergman, chairman and CEO of Henry Schein, discussed the potential global impact of a world without effective antibiotics before an audience of business, political,
Stanley Bergman, chairman and CEO of Henry Schein, discussed the potential global impact of a world without effective antibiotics before an audience of business, political,
Will Washington become the next U.S. state to adopt the midlevel provider (MLP) model? Washington lawmakers will decide in the next few days whether to
The Manhattan Tobacco Cessation Program at the New York University (NYU) School of Medicine has developed a tool kit for dental practitioners who want to
J. Morita USA will no longer supply the AZ Ultrasonic piezo scaling system, effective immediately. This decision was made to allow the company to focus
Smoking doubles the risk of developing esophageal cancer in people with Barrett’s esophagus, according to a new study in Gastroenterology (January 13, 2012). The study,
Using ornidazole in conjunction with scaling and root planing achieves significantly better clinical results in treating moderate to advanced chronic periodontitis than periodontal treatment alone,
Patients treated with intensity-modulated radiation therapy (IMRT) for head and neck cancer reported increasingly better quality of life after treatment than patients receiving other forms
Grape seed extract can kill head and neck squamous cell carcinoma cells in both cell lines and mouse models while leaving healthy cells unharmed, according
Radiation therapy with or without chemotherapy is less effective for patients with HIV when compared with the recurrence and overall survival rates in patients who
Aetna is piloting a program to support dentists in adopting the U.S. Public Health Service’s (USPHS) five A’s tobacco cessation guidelines: Ask, Advise, Assess, Assist,
A saliva self-test used to diagnose human immunodeficiency virus (HIV) is comparable in accuracy to the traditional blood test, according to a new study in
Researchers at Albert Einstein College of Medicine and the University Hospital for Einstein have found a biomarker in head and neck cancers that can predict